Salzhauer Michael Pfizer Inc Call Options Transaction History

Salzhauer Michael

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $245,622 - $319,036	9,400 New	9,400 $270,000
Q4 2021 Feb 04, 2022	SELL	$41.32 - $61.25 $446,256 - $661,500	-10,800 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $23,550 - $30,252	600 Added 5.88%	10,800 $79,000
Q2 2021 Aug 06, 2021	SELL	$35.91 - $40.68 $172,367 - $195,264	-4,800 Reduced 32.0%	10,200 $74,000
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $167,450 - $188,850	5,000 Added 50.0%	15,000 $56,000

Q4 2020 Jan 29, 2021	BUY	$33.47 - $42.56 $66,940 - $85,120	2,000 Added 25.0%	10,000 $50,000
Q3 2020 Nov 09, 2020	BUY	$31.75 - $37.25 $254,000 - $298,000	8,000 New	8,000 $13,000
Q2 2020 Aug 05, 2020	SELL	$30.12 - $36.54 $240,960 - $292,320	-8,000 Closed	0 $0
Q3 2019 Nov 06, 2019	BUY	$32.49 - $42.13 $87,723 - $113,751	2,700 Added 50.94%	8,000 $17,000
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $180,809 - $206,142	-4,700 Reduced 47.0%	5,300 $58,000
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $310,000 - $341,500	10,000	10,000 $44,000

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Salzhauer Michael, based on Form 13F filings with the SEC.

Stay updated on Salzhauer Michael with notifications on news.